Doximity Inc. (DOCS) Dividend Safety Gauge & 10-Year DRIP Compounder

$32.76 -2.59% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $32.69

Doximity Inc. (DOCS) earns a Roarable Rating of A- (Buy) with 84/100 RQD Confidence. High-quality cash engine (89% profit margin, 17% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE A- β€’ STRONG BUY Cap $5.99B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on DOCS Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is DOCS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Doximity Inc. (NYSE: DOCS) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 84/100 at a spot price of $32.76 (-2.59% 1D, market cap $5.99B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 18/20, and SEC Balance-Sheet Forensics 15/20. Across 714 tracked Technology issuers, DOCS ranks #4 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does DOCS compare to APLD and SAIC in the Technology sector?
β–Ό

Within the Technology sector (EDP Services), DOCS carries a Roarable A- (84/100 RQD), trailing P/E of 30.6x, gross margin of 89.1%, and ROIC of 17.2%. By comparison, APLD (Applied Digital Corporation) holds a D- grade (37/100 RQD, P/E N/A, ROIC -21.7%, cap $5.87B) and SAIC (Science Applications International Corporation) posts a B+ grade (76/100 RQD, P/E 17.7x, ROIC 10.9%, cap $6.32B). Among the 5-stock peer group, PEGA leads on earnings multiple (14.2x) while PEGA leads on capital efficiency (22.4% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for DOCS?
β–Ό

Per DOCS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001516513), Doximity Inc. generated $644.9M in revenue (+13.1% YoY), $196.1M in net income, and $326.5M in free cash flow against $1.16B in total assets and $80.0M in total debt. Key quantitative strengths: Strong cash generator (89% profit margin)β€”profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $32.68 (-0.23%)🧬 Cannibal Buyback (-2.08% YoY Shares)βš™οΈ Cash Engine: 18/20 (A) β€’ 50.6% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 84/100 (A-) historically ranked in the Top 6% of excess returns over the next 90 days (+8.9% avg 90D alpha vs SPY β€’ 72.6% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSTRONG BUY β€’ A-
025507510084
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B+ Β· Rk A
Cash (18)Whales (15)SEC (18)Macro (18)CEO (15)
Each axis scored 0–20
12M PRICE TARGET CONE+11.7% Base Target
$70 Bull$37 Base$27 Bear
πŸ“¬ FREE DOCS RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for DOCS)Realized 20D OHLCV Swing Band: Β±8.2%
Deterministic 5-Pillar Attribution (84/100 Composite)
πŸ” WHY DOCS SCORES 84/100 (A-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Cash Engine Quality+18/20 pts (21% of score)

SEC XBRL FY 2025 (10-K): 50.6% FCF Margin ($326.5M FCF) & 89.1% Gross Margin

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (21% of score)

Altman Z-Score 22.31 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 8/9

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution15/20 pts (-5 pt drag)

Cannibal Buyback (-2.08% YoY Shares) & executive Form 4 sales trim 5 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
76
Grade B+$30.55+9.2% Next Q
Q2 (-2Q)
79
Grade A-$33.35-0.3% Next Q
Q3 (-1Q)
81
Grade A-$33.24-1.4% Next Q
Current
84
Grade A-$32.76+8.9% Hist 90D Ξ±
Trajectory: B+ (76) β†’ A- (84)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the DOCS Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 84/100 (A-) score, DOCS faces multiple-compression risk if 30.6x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) β€” any gross margin slip below 86.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($28.63) or 200D SMA ($25.47) invalidates the momentum regime and cuts Target Base ($36.59) toward Bear Floor ($26.86).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $DOCSβ€’ $4.8M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œDOCS Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
CASH DIVIDEND + BUYBACK YIELD
1.8% Total Yield
0% Cash ($0.00/yr) + 1.8% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 β€’ REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (9% EST. ANNUAL)

$10,000 Compounded Over 10 Years β†’ $23,674

Est. Year-10 Shareholder Yield: $426/yr
$10.9K
Yr 1
$11.9K
Yr 2
$13.0K
Yr 3
$14.1K
Yr 4
$15.4K
Yr 5
$16.8K
Yr 6
$18.3K
Yr 7
$19.9K
Yr 8
$21.7K
Yr 9
$23.7K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in DOCS & A-Rated Leaders

  • βœ“12-month Bull/Base/Bear fair-value walkthrough on DOCS and its top sector peer
  • βœ“Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
DOCS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +31.62%⚑ TESTING RESISTANCE
2026-11-02O $34.25H $34.25L $32.76C $32.76VOL 2.73M
RES: $34.53SUP: $29.27SMA50: $28.63SMA200: $25.47
$49.49$40.72$31.96$23.19$14.43RES $34.53SUP $29.27$32.762026-05-042026-06-172026-08-042026-09-182026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DOCS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
23.6%/yr Implied 5Y Growth

vs. +13.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DOCS today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for DOCS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DOCS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DOCS)

1. Head-to-Head Technology Peer Comparison (DOCS vs. APLD, SAIC, PEGA, WAY)

Industry: EDP Services (163 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Doximity Inc. (DOCS) ranks #4 by composite RQD confidence (84/100, grade A-) and #195 by equity capitalization ($5.99B). Within this direct 5-issuer industry benchmark cohort, PEGA leads on earnings valuation at 14.2x trailing P/E, while PEGA leads on capital efficiency and profitability with 22.4% ROIC and 75.9% gross margin. DOCS currently leads its immediate peer cohort in composite quantitative strength at 84/100 (A-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
DOCS ACTIVE
Doximity Inc.
A- 84/100 30.6x 89.1% 17.2% -2.59% $5.99B Benchmark Subject
APLD
Applied Digital Corporation
D- 37/100 β€” 35.1% -21.7% -8.22% $5.87B /apld-vs-docs β†’
SAIC
Science Applications International Corporation
B+ 76/100 17.7x 12.0% 10.9% +0.67% $6.32B /saic-vs-docs β†’
PEGA
Pegasystems Inc.
B 73/100 14.2x 75.9% 22.4% -0.53% $5.58B /pega-vs-docs β†’
WAY
Waystar Holding Corp.
C 64/100 48.3x β€” 3.7% -0.74% $5.41B /way-vs-docs β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2026-03-31 β€’ CIK 0001516513

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Doximity Inc. (DOCS) reported GAAP revenue of $644.9M (+13.1% vs. FY2024 revenue of $570.4M , and +35.6% cumulative change since FY2023) , GAAP net income of $196.1M, operating cash flow of $326.5M, and free cash flow of $326.5M (+19.5% YoY). On the balance sheet, DOCS closed FY2025 with $1.16B in total assets against $80.0M in total debt (Altman Z-Score: 22.31, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-03-31 $644.9M $196.1M $326.5M $326.5M $1.16B $80.0M
FY2024 (FY) 2025-03-31 $570.4M $223.2M $273.3M $273.3M $1.17B $63.5M
FY2023 (FY) 2024-03-31 $475.4M $147.6M $184.1M $162.7M $3.30B $771.5M

3. DOCS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is DOCS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Doximity Inc. (NYSE: DOCS) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 84/100 at a spot price of $32.76 (-2.59% 1D, market cap $5.99B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 15/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 18/20, and SEC Balance-Sheet Forensics 15/20. Across 714 tracked Technology issuers, DOCS ranks #4 in composite RQD confidence.

How does DOCS compare to APLD and SAIC in the Technology sector?

Within the Technology sector (EDP Services), DOCS carries a Roarable A- (84/100 RQD), trailing P/E of 30.6x, gross margin of 89.1%, and ROIC of 17.2%. By comparison, APLD (Applied Digital Corporation) holds a D- grade (37/100 RQD, P/E N/A, ROIC -21.7%, cap $5.87B) and SAIC (Science Applications International Corporation) posts a B+ grade (76/100 RQD, P/E 17.7x, ROIC 10.9%, cap $6.32B). Among the 5-stock peer group, PEGA leads on earnings multiple (14.2x) while PEGA leads on capital efficiency (22.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for DOCS?

Per DOCS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001516513), Doximity Inc. generated $644.9M in revenue (+13.1% YoY), $196.1M in net income, and $326.5M in free cash flow against $1.16B in total assets and $80.0M in total debt. Key quantitative strengths: Strong cash generator (89% profit margin)β€”profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is DOCS trading relative to its 50-day, 200-day, and 52-week technical levels?

DOCS last traded at $32.76 (-2.59% on volume of 2,202,470 shares), positioning the stock +14.43% above its 50-day simple moving average ($28.63) and +28.62% above its 200-day simple moving average ($25.47). Across its 52-week range of $17.15 to $67.10, DOCS sits at the 31.3% percentile with a 14-day RSI of 65.4 (BULLISH MOMENTUM) and an implied next-earnings move of Β±8.2% ($30.07 to $35.45).

DOCS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Does DOCS pay a dividend and is it safe?

Doximity Inc. (DOCS) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

ROARABLE RATING BRIEF β€’ RQD 84/100 (A-) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

DOCS β€” Doximity Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:19:33Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, DOCS carries an RQD Score of 84 and a letter grade of A-, labeled "Roarable Buy β€” Superior Risk/Reward." The five pillars are: Fundamental Cash Engine at 18/20 (ROIC 17.2%; FCF yield 5.45%), Whale 13F Flow at 15/20 (institutional accumulation and options positioning), Insider Conviction at 15/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 18/20 (Beta 1.25; sector sensitivity), and Forensic Balance Sheet at 18/20 (Altman Z 22.31; Piotroski F 8/9; Debt/Equity 0.08). The strongest pillars are cash generation and balance-sheet forensics; the weakest are institutional and insider flow, which score 15/20 each. For a prospective investor, the rating points to strong cash conversion and low leverage as supporting the valuation, while the 1.25 beta indicates above-market price sensitivity. The stock's 52-week range of $17.15 to $67.10 and current price of $33.63 show substantial price volatility within the observed period. Valuation tradeoffs are visible in the multiples: P/E (TTM) of 30.6 and EV/EBITDA of 27.9 are elevated relative to the forward P/E of 25.7. This is an analytical summary of source data, not personalized advice.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
$33.63$5.99B30.625.727.91.10%1.25$17.15 - $67.117.2%

Business

Per the profile, Doximity Inc. is a NYSE-listed issuer in the Technology sector, within the EDP Services industry. The source data does not describe its products, customers, or revenue model. Per the market data, the company reports a gross margin of 89.1% and an operating margin of 33.3%. Not available in source data for further business description.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025 (filed 2026-03-31)$644.9M$214.9M$196.1MN/A$326.5M$64.8M$80.0M
FY 2024 (filed 2025-03-31)$570.4M$227.8M$223.2MN/A$273.3M$165.3M$63.5M
FY 2023 (filed 2024-03-31)$475.4M$163.9M$147.6MN/A$162.7MN/A$771.5M

Per the SEC financials, revenue rose from $475.4M in FY 2023 to $644.9M in FY 2025, while net income moved from $147.6M to $196.1M after peaking at $223.2M in FY 2024. Per the market data, the operating margin is 33.3% and net margin is 30.4%. The Roarable RQD rating cites ROIC of 17.2%, an Altman Z-Score of 22.31, a Piotroski F-Score of 8/9, and Debt/Equity of 0.08. Reported debt declined from $771.5M in FY 2023 to $80.0M in FY 2025.

Recent Catalysts & News Wire Analysis

Per the news wire, the headlines are dated within the prior roughly 15 hours of the data timestamp. The most significant items are:

  • A GREEN-flagged CATALYST item: a TradingView report of a 12-month price target raised to $31.05, implying 1% downside.
  • A RED-flagged RISK WATCH item: a Morningstar report carrying a shareholder-rights solicitation headline referencing Robbins LLP.
  • YELLOW-flagged MARKET WIRE items from Yahoo Finance, Yahoo Finance Canada, and GuruFocus covering stock price action, institutional positioning, and valuation commentary, including a report that the stock was "rocketing higher" and another reporting a 3.8% gain.

Per the Butterfly Supply-Chain Graph, there are no supply-chain links and no proprietary signals recorded. The source summaries are generic and do not specify the fundamental drivers behind the price moves.

Open Questions

  • What are the company's principal products and customer base, given that the source data contains only sector and industry classification?
  • What drove the FY 2024 to FY 2025 change in net income relative to operating income, and what explains the decline in cash from $165.3M to $64.8M?
  • What are the EPS figures for each reported period, given that the financials list EPS as N/A?
  • What specific institutional and insider transactions underlie the 15/20 whale flow and insider conviction scores?
  • What does the RED-flagged shareholder-rights headline indicate about any pending legal matter, and is any such matter disclosed in the filings?

DOCS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Doximity Inc. (DOCS) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to DOCS Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

DOCS Bull vs. Bear Conversation Board β€” What's Your Call at $32.76?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DOCS 🐻 33% BEARISH CONVICTION
1. Pick Your Side on DOCS:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk πŸ‚ BULLISH 🎯 Target: $39.68 (+18.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is DOCS (A- β€’ RQD 84/100) a Buy at $33.63?

Welcome to the DOCS (Doximity Inc.) Roar Pit. Current RQD Composite is 84/100 (Roarable Buy β€” Superior Risk/Reward) in EDP Services. Bulls point to capital efficiency (17.2% ROIC), while bears focus on valuation multiple compression (30.6x trailing P/E). Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $25.22 (-25.0%)
Spot @ $33.63

Pump the brakes on DOCS β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on DOCS, but look at what you are paying: 30.6x trailing P/E with 89.1% gross margins. Unless Doximity Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MA MacroHawk_NYC Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $43.05 (+28.0%)
Spot @ $33.63

DOCS cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on DOCS, the market is fixating on short-term headline noise in EDP Services and ignoring the balance sheet and cash flow trajectory. At $33.63 (52-wk range $17.15 - $67.10), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%